oru.sePublikationer
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Effects on the anti-ABO titers of military blood donors from a predeployment vaccination program.
Örebro University, School of Medical Sciences. the Department for Transfusion Medicine, Örebro University Hospital, Örebro, Sweden.
2017 (English)In: Journal of Trauma and Acute Care Surgery, ISSN 2163-0755, E-ISSN 2163-0763Article in journal (Refereed) Epub ahead of print
Abstract [en]

BACKGROUND: The use of blood group O as "universal blood" for emergency whole blood transfusions carries the risk for a hemolytic transfusion reaction mediated by incompatible A-/B-antibodies. This risk can be minimized by assuring that the donor has a low titer of anti-A and anti-B. The level of these naturally occurring antibodies have been shown to be increased by vaccination with most biologically derived vaccines. This boostering effect has been investigated for the new generation of vaccines.

METHODS: The 120 crew members of a Swedish naval ship deployed for seven months to the Indian Ocean were tested for anti-A and anti-B before their predeployment vaccination program and after returning to Sweden. The vaccination program contained vaccines against cholera, diphtheria, hepatitis A and B, influenza, measles, meningitis, mumps, pertussis, polio, rubella, TBE-virus, tetanus, typhus and yellow fever. Paired antibody titrations were performed for both IgM and IgG using microtube gelcards (Diamed GMBH).

RESULTS: No crew member, including the six belonging to the "high titer" group, showed a sign of a booster effect by any of the used vaccines.

CONCLUSION: The earlier reported boostering effects mediated by different vaccines is not be replicated with the new vaccines of today. This is probably a result of the new manufacturing techniques resulting in much purer vaccines.

LEVEL OF EVIDENCE: Diagnostic test or criteria, level V.

Place, publisher, year, edition, pages
2017.
National Category
Immunology in the medical area
Research subject
Immunology
Identifiers
URN: urn:nbn:se:oru:diva-57372DOI: 10.1097/TA.0000000000001420PubMedID: 28301394Scopus ID: 2-s2.0-85015649102OAI: oai:DiVA.org:oru-57372DiVA: diva2:1093926
Available from: 2017-05-08 Created: 2017-05-08 Last updated: 2017-09-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Berséus, Olle
By organisation
School of Medical Sciences
In the same journal
Journal of Trauma and Acute Care Surgery
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 17 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf